1. Home
  2. TPC vs ADPT Comparison

TPC vs ADPT Comparison

Compare TPC & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tutor Perini Corporation

TPC

Tutor Perini Corporation

HOLD

Current Price

$88.08

Market Cap

3.1B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$16.32

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPC
ADPT
Founded
1894
2009
Country
United States
United States
Employees
N/A
N/A
Industry
General Bldg Contractors - Nonresidential Bldgs
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2003
2019

Fundamental Metrics

Financial Performance
Metric
TPC
ADPT
Price
$88.08
$16.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$82.00
$17.78
AVG Volume (30 Days)
549.0K
1.7M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
0.28%
N/A
EPS Growth
5.15
30.77
EPS
0.97
N/A
Revenue
$4,326,922,000.00
$178,957,000.00
Revenue This Year
$25.77
$3.98
Revenue Next Year
$14.81
$22.72
P/E Ratio
$88.76
N/A
Revenue Growth
11.51
5.10
52 Week Low
$18.34
$6.26
52 Week High
$89.40
$20.76

Technical Indicators

Market Signals
Indicator
TPC
ADPT
Relative Strength Index (RSI) 67.47 48.45
Support Level $80.00 $14.91
Resistance Level $89.40 $17.91
Average True Range (ATR) 3.93 0.90
MACD 0.09 0.01
Stochastic Oscillator 91.60 49.16

Price Performance

Historical Comparison
TPC
ADPT

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: